Emmes contributes data services to pediatric COVID-19 research
Emmes contributes data services to pediatric COVID-19 research

Emmes contributes data services to pediatric COVID-19 research

The Clinical Research Organization (CRO) has announced that it has been used as a data coordinating center on a team that pursues pediatric COVID-19 research through pharmacokinetics, pharmacodynamics and safety profile of studied drugs administered to children per. care standard (POP02). The team (led by Duke University’s Pediatric Trials Network) also includes the Gabriella Miller Kids First Data Resource Center (DRC) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

POP02 is among the several cohort studies within the collaboration to assess risk and identify long-term outcomes for children with COVID, known as CARING for Children with COVID. The National Institutes of Health (NIH) launched the CARING for Children with COVID program to collect clinical data and samples that would advance the understanding of SARS-CoV-2 infections in children.

According to the team, the program seeks to provide information to help healthcare providers and parents make informed decisions when caring for children who are infected with either COVID-19 (acute coronavirus disease) or who have MIS-C (multisystem inflammatory syndrome). . Data from the POP02 study were used to develop and pilot tools that utilized the Health Level Seven International (HL7) Fast Healthcare Interoperability Resources (FHIR) standard; the tools and resources are said to be used to promote and accelerate the release of pediatric COVID-19 clinical data.

To learn more about the project, Outsourcing-Pharma contacted two Emmes representatives:

Leave a Reply

Your email address will not be published.